Search for Clinical Trial Results
Monoclonal Gammopathy of Undetermined Significance - 18 Studies Found
| Status | Study |
| Completed |
Study Name: Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma Condition:
|
| Completed |
Study Name: Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma Condition:
|
| Completed |
Study Name: RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy Condition: Polyneuropathy Date: 2005-11-29 Interventions: Drug: Rituximab Rituximab |
| Completed |
Study Name: Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With Tuberculosis Condition:
Date: 2005-09-12 |
| Terminated |
Study Name: Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma Condition:
Date: 2009-07-17 Interventions:
|
| Withdrawn |
Study Name: Imaging Studies and the Development of Multiple Myeloma Condition:
|
| Completed |
Study Name: Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma Condition: Multiple Myeloma and Plasma Cell Neoplasm Date: 2000-09-11 Interventions:
|